nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—ABCC2—esophageal cancer	0.481	1	CbGaD
Pranlukast—ABCC2—Carboplatin—esophageal cancer	0.0746	0.306	CbGbCtD
Pranlukast—ABCC2—Cisplatin—esophageal cancer	0.0638	0.262	CbGbCtD
Pranlukast—CYP2C9—Capecitabine—esophageal cancer	0.0425	0.174	CbGbCtD
Pranlukast—ABCC2—Methotrexate—esophageal cancer	0.0414	0.17	CbGbCtD
Pranlukast—CYP2C9—Cisplatin—esophageal cancer	0.0214	0.0879	CbGbCtD
Pranlukast—IL5—exocrine gland—esophageal cancer	0.0141	0.144	CbGeAlD
Pranlukast—MUC2—exocrine gland—esophageal cancer	0.0108	0.111	CbGeAlD
Pranlukast—RNASE3—bronchus—esophageal cancer	0.00663	0.0679	CbGeAlD
Pranlukast—IL5—epithelium—esophageal cancer	0.00611	0.0626	CbGeAlD
Pranlukast—IL5—bronchus—esophageal cancer	0.00602	0.0617	CbGeAlD
Pranlukast—RNASE3—digestive system—esophageal cancer	0.00512	0.0525	CbGeAlD
Pranlukast—MUC2—epithelium—esophageal cancer	0.0047	0.0482	CbGeAlD
Pranlukast—IL5—digestive system—esophageal cancer	0.00465	0.0477	CbGeAlD
Pranlukast—RNASE3—lung—esophageal cancer	0.00428	0.0438	CbGeAlD
Pranlukast—IL5—lung—esophageal cancer	0.00388	0.0398	CbGeAlD
Pranlukast—MUC2—digestive system—esophageal cancer	0.00358	0.0366	CbGeAlD
Pranlukast—MUC2—lung—esophageal cancer	0.00299	0.0306	CbGeAlD
Pranlukast—IL5—lymph node—esophageal cancer	0.00266	0.0272	CbGeAlD
Pranlukast—NFKB1—bronchus—esophageal cancer	0.00264	0.027	CbGeAlD
Pranlukast—CYSLTR1—bronchus—esophageal cancer	0.00259	0.0266	CbGeAlD
Pranlukast—CYSLTR1—smooth muscle tissue—esophageal cancer	0.00254	0.026	CbGeAlD
Pranlukast—NFKB1—trachea—esophageal cancer	0.00237	0.0243	CbGeAlD
Pranlukast—TNF—lymph node—esophageal cancer	0.00204	0.0209	CbGeAlD
Pranlukast—NFKB1—digestive system—esophageal cancer	0.00204	0.0209	CbGeAlD
Pranlukast—NFKB1—lung—esophageal cancer	0.0017	0.0175	CbGeAlD
Pranlukast—CYSLTR1—lung—esophageal cancer	0.00167	0.0171	CbGeAlD
Pranlukast—NFKB1—lymph node—esophageal cancer	0.00116	0.0119	CbGeAlD
Pranlukast—CYSLTR1—lymph node—esophageal cancer	0.00114	0.0117	CbGeAlD
Pranlukast—Candesartan—PTGS1—esophageal cancer	0.00114	0.673	CrCbGaD
Pranlukast—ABCC2—digestive system—esophageal cancer	0.000801	0.0082	CbGeAlD
Pranlukast—Candesartan—ABCB1—esophageal cancer	0.000555	0.327	CrCbGaD
Pranlukast—CYP2C9—digestive system—esophageal cancer	0.000533	0.00547	CbGeAlD
Pranlukast—ABCC2—lymph node—esophageal cancer	0.000457	0.00469	CbGeAlD
Pranlukast—CYP3A4—digestive system—esophageal cancer	0.000407	0.00417	CbGeAlD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—TP53—esophageal cancer	3.58e-05	0.000203	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	3.53e-05	0.0002	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	3.53e-05	0.0002	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PSME2—esophageal cancer	3.52e-05	0.000199	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PSME1—esophageal cancer	3.52e-05	0.000199	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ANXA1—esophageal cancer	3.5e-05	0.000199	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SMAD4—esophageal cancer	3.48e-05	0.000197	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	3.48e-05	0.000197	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—EGFR—esophageal cancer	3.47e-05	0.000197	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—PIK3CA—esophageal cancer	3.46e-05	0.000196	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	3.43e-05	0.000194	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—esophageal cancer	3.41e-05	0.000193	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SST—esophageal cancer	3.41e-05	0.000193	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CSNK1A1—esophageal cancer	3.39e-05	0.000192	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ACTB—esophageal cancer	3.38e-05	0.000191	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CDKN1A—esophageal cancer	3.36e-05	0.000191	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—ABL1—esophageal cancer	3.35e-05	0.00019	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TP53—esophageal cancer	3.35e-05	0.00019	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—KDR—esophageal cancer	3.33e-05	0.000189	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TP53—esophageal cancer	3.32e-05	0.000188	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NOTCH3—esophageal cancer	3.32e-05	0.000188	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GHRL—esophageal cancer	3.32e-05	0.000188	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	3.32e-05	0.000188	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PTPN2—esophageal cancer	3.3e-05	0.000187	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TP53—esophageal cancer	3.29e-05	0.000186	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—FBXW7—esophageal cancer	3.27e-05	0.000185	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	3.26e-05	0.000185	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—B2M—esophageal cancer	3.26e-05	0.000185	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MET—esophageal cancer	3.26e-05	0.000185	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—PIK3CA—esophageal cancer	3.26e-05	0.000185	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—SMAD4—esophageal cancer	3.24e-05	0.000184	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—EP300—esophageal cancer	3.2e-05	0.000181	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PFN1—esophageal cancer	3.17e-05	0.00018	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	3.16e-05	0.000179	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—CDKN1A—esophageal cancer	3.15e-05	0.000179	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—NOTCH1—esophageal cancer	3.14e-05	0.000178	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	3.11e-05	0.000176	CbGpPWpGaD
Pranlukast—IL5—Immune System—BCL2—esophageal cancer	3.1e-05	0.000176	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PSME1—esophageal cancer	3.08e-05	0.000175	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PSME2—esophageal cancer	3.08e-05	0.000175	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	3.07e-05	0.000174	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.07e-05	0.000174	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HSPA5—esophageal cancer	3.05e-05	0.000173	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—MYC—esophageal cancer	3.05e-05	0.000173	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—TP53—esophageal cancer	3.03e-05	0.000172	CbGpPWpGaD
Pranlukast—IL5—Immune System—ERBB2—esophageal cancer	3.02e-05	0.000171	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—PIK3CA—esophageal cancer	3.02e-05	0.000171	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—PIK3CA—esophageal cancer	3.01e-05	0.000171	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—EGFR—esophageal cancer	2.98e-05	0.000169	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NOTCH2—esophageal cancer	2.98e-05	0.000169	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.97e-05	0.000168	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CALR—esophageal cancer	2.96e-05	0.000168	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—TLR4—esophageal cancer	2.94e-05	0.000167	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	2.91e-05	0.000165	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—FBXW7—esophageal cancer	2.86e-05	0.000162	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HIF1A—esophageal cancer	2.85e-05	0.000162	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ELMO1—esophageal cancer	2.85e-05	0.000161	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—CREBBP—esophageal cancer	2.84e-05	0.000161	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AKAP13—esophageal cancer	2.78e-05	0.000158	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.75e-05	0.000156	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HMGB1—esophageal cancer	2.73e-05	0.000155	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—KDR—esophageal cancer	2.73e-05	0.000155	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.69e-05	0.000153	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.68e-05	0.000152	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—esophageal cancer	2.67e-05	0.000151	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TGFBR2—esophageal cancer	2.64e-05	0.00015	CbGpPWpGaD
Pranlukast—IL5—Immune System—CDKN1A—esophageal cancer	2.58e-05	0.000146	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NOTCH1—esophageal cancer	2.57e-05	0.000146	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HIST1H2BM—esophageal cancer	2.57e-05	0.000146	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.57e-05	0.000146	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—EGFR—esophageal cancer	2.56e-05	0.000145	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PDE4D—esophageal cancer	2.54e-05	0.000144	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—KDR—esophageal cancer	2.54e-05	0.000144	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CASP8—esophageal cancer	2.52e-05	0.000143	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CREBBP—esophageal cancer	2.51e-05	0.000142	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TP53—esophageal cancer	2.5e-05	0.000142	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SMAD4—esophageal cancer	2.5e-05	0.000142	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MET—esophageal cancer	2.48e-05	0.000141	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	2.47e-05	0.00014	CbGpPWpGaD
Pranlukast—IL5—Immune System—EP300—esophageal cancer	2.45e-05	0.000139	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	2.44e-05	0.000139	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	2.44e-05	0.000138	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GNG7—esophageal cancer	2.42e-05	0.000137	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—NOTCH1—esophageal cancer	2.39e-05	0.000136	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—ERBB2—esophageal cancer	2.38e-05	0.000135	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.34e-05	0.000132	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CREBBP—esophageal cancer	2.33e-05	0.000132	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	2.33e-05	0.000132	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	2.29e-05	0.00013	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—TP53—esophageal cancer	2.29e-05	0.00013	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—EGFR—esophageal cancer	2.29e-05	0.00013	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—XIAP—esophageal cancer	2.27e-05	0.000129	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ABL1—esophageal cancer	2.26e-05	0.000128	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.26e-05	0.000128	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—PIK3CA—esophageal cancer	2.26e-05	0.000128	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—PIK3CA—esophageal cancer	2.22e-05	0.000126	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—PIK3CA—esophageal cancer	2.19e-05	0.000124	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—CREBBP—esophageal cancer	2.17e-05	0.000123	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—BCL2—esophageal cancer	2.17e-05	0.000123	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CTNNA1—esophageal cancer	2.15e-05	0.000122	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCL2—esophageal cancer	2.13e-05	0.000121	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	2.13e-05	0.000121	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—ERBB2—esophageal cancer	2.1e-05	0.000119	CbGpPWpGaD
Pranlukast—IL5—Immune System—EGFR—esophageal cancer	2.09e-05	0.000119	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NOS3—esophageal cancer	2.08e-05	0.000118	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HIF1A—esophageal cancer	2.05e-05	0.000116	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—ERBB2—esophageal cancer	2.02e-05	0.000115	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PSME1—esophageal cancer	1.99e-05	0.000113	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PSME2—esophageal cancer	1.99e-05	0.000113	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—PIK3CA—esophageal cancer	1.99e-05	0.000113	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ANXA1—esophageal cancer	1.98e-05	0.000112	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—KDR—esophageal cancer	1.96e-05	0.000111	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ERBB2—esophageal cancer	1.95e-05	0.000111	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—EP300—esophageal cancer	1.94e-05	0.00011	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SST—esophageal cancer	1.93e-05	0.000109	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—BLVRB—esophageal cancer	1.9e-05	0.000107	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC52A3—esophageal cancer	1.9e-05	0.000107	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NOTCH3—esophageal cancer	1.88e-05	0.000107	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GHRL—esophageal cancer	1.88e-05	0.000107	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—FBXW7—esophageal cancer	1.85e-05	0.000105	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NOTCH1—esophageal cancer	1.84e-05	0.000104	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—ERBB2—esophageal cancer	1.82e-05	0.000103	CbGpPWpGaD
Pranlukast—IL5—Immune System—PIK3CA—esophageal cancer	1.81e-05	0.000103	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CDKN1A—esophageal cancer	1.8e-05	0.000102	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CDKN1A—esophageal cancer	1.73e-05	9.79e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CCND1—esophageal cancer	1.72e-05	9.77e-05	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.72e-05	9.73e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—TLR4—esophageal cancer	1.71e-05	9.71e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—EP300—esophageal cancer	1.71e-05	9.7e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	1.69e-05	9.6e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NOTCH2—esophageal cancer	1.69e-05	9.56e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CREBBP—esophageal cancer	1.67e-05	9.47e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CDKN1A—esophageal cancer	1.67e-05	9.45e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—EGFR—esophageal cancer	1.65e-05	9.36e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—EGFR—esophageal cancer	1.64e-05	9.31e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC10A2—esophageal cancer	1.61e-05	9.14e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CA1—esophageal cancer	1.61e-05	9.14e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—EP300—esophageal cancer	1.59e-05	8.99e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.57e-05	8.9e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NOS3—esophageal cancer	1.5e-05	8.48e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TGFBR2—esophageal cancer	1.5e-05	8.48e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—EP300—esophageal cancer	1.48e-05	8.37e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CA2—esophageal cancer	1.47e-05	8.36e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CASP8—esophageal cancer	1.47e-05	8.33e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CREBBP—esophageal cancer	1.46e-05	8.3e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—EGFR—esophageal cancer	1.46e-05	8.27e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.44e-05	8.17e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—PIK3CA—esophageal cancer	1.43e-05	8.08e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SMAD4—esophageal cancer	1.42e-05	8.03e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—EGFR—esophageal cancer	1.4e-05	7.94e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ERBB2—esophageal cancer	1.4e-05	7.93e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MYC—esophageal cancer	1.38e-05	7.83e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ADH7—esophageal cancer	1.37e-05	7.77e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PLCE1—esophageal cancer	1.37e-05	7.77e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.35e-05	7.68e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—EGFR—esophageal cancer	1.35e-05	7.66e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—PIK3CA—esophageal cancer	1.27e-05	7.18e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—BCL2—esophageal cancer	1.26e-05	7.15e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—EGFR—esophageal cancer	1.26e-05	7.13e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.25e-05	7.09e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.25e-05	7.09e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CCND1—esophageal cancer	1.24e-05	7.01e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ERBB2—esophageal cancer	1.23e-05	6.95e-05	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—PIK3CA—esophageal cancer	1.22e-05	6.89e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ADH1B—esophageal cancer	1.2e-05	6.81e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CDKN1A—esophageal cancer	1.2e-05	6.78e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PIK3CA—esophageal cancer	1.17e-05	6.65e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HIF1A—esophageal cancer	1.16e-05	6.57e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TYMP—esophageal cancer	1.15e-05	6.51e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—EP300—esophageal cancer	1.14e-05	6.45e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TP53—esophageal cancer	1.13e-05	6.43e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.12e-05	6.33e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—KDR—esophageal cancer	1.11e-05	6.28e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.09e-05	6.17e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CA1—esophageal cancer	1.06e-05	6.02e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.06e-05	6.02e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CDKN1A—esophageal cancer	1.05e-05	5.94e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NOTCH1—esophageal cancer	1.04e-05	5.92e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TPI1—esophageal cancer	1.04e-05	5.89e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.04e-05	5.89e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—EP300—esophageal cancer	9.97e-06	5.65e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ALDOB—esophageal cancer	9.96e-06	5.64e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MYC—esophageal cancer	9.92e-06	5.62e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CA2—esophageal cancer	9.72e-06	5.51e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—EGFR—esophageal cancer	9.7e-06	5.5e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GAPDH—esophageal cancer	9.58e-06	5.43e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CRABP1—esophageal cancer	9.5e-06	5.38e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CREBBP—esophageal cancer	9.46e-06	5.36e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PLCE1—esophageal cancer	9.04e-06	5.12e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ADH7—esophageal cancer	9.04e-06	5.12e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GNG7—esophageal cancer	9.03e-06	5.12e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—EGFR—esophageal cancer	8.49e-06	4.82e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NOS3—esophageal cancer	8.47e-06	4.8e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ALDH2—esophageal cancer	8.46e-06	4.8e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PIK3CA—esophageal cancer	8.42e-06	4.77e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TP53—esophageal cancer	8.14e-06	4.62e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTT1—esophageal cancer	8.05e-06	4.56e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP2A6—esophageal cancer	7.96e-06	4.51e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.93e-06	4.49e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ADH1B—esophageal cancer	7.92e-06	4.49e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ERBB2—esophageal cancer	7.92e-06	4.49e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TYMP—esophageal cancer	7.57e-06	4.29e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS1—esophageal cancer	7.54e-06	4.28e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ENO1—esophageal cancer	7.54e-06	4.28e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PSME2—esophageal cancer	7.43e-06	4.21e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PSME1—esophageal cancer	7.43e-06	4.21e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—PIK3CA—esophageal cancer	7.37e-06	4.18e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP26A1—esophageal cancer	7.37e-06	4.18e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ALOX15—esophageal cancer	7.18e-06	4.07e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CCND1—esophageal cancer	7e-06	3.97e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.85e-06	3.88e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TPI1—esophageal cancer	6.85e-06	3.88e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CDKN1A—esophageal cancer	6.77e-06	3.84e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.57e-06	3.72e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.49e-06	3.68e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EP300—esophageal cancer	6.44e-06	3.65e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP1B1—esophageal cancer	6.42e-06	3.64e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GAPDH—esophageal cancer	6.32e-06	3.58e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CRABP1—esophageal cancer	6.26e-06	3.55e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP19A1—esophageal cancer	6.03e-06	3.42e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GNG7—esophageal cancer	5.96e-06	3.38e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MYC—esophageal cancer	5.62e-06	3.18e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.58e-06	3.16e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HMOX1—esophageal cancer	5.5e-06	3.12e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EGFR—esophageal cancer	5.49e-06	3.11e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.4e-06	3.06e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.31e-06	3.01e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ABCB1—esophageal cancer	5.28e-06	2.99e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.25e-06	2.98e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.98e-06	2.82e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ENO1—esophageal cancer	4.98e-06	2.82e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PSME2—esophageal cancer	4.9e-06	2.78e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PSME1—esophageal cancer	4.9e-06	2.78e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PIK3CA—esophageal cancer	4.77e-06	2.7e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TP53—esophageal cancer	4.61e-06	2.61e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.23e-06	2.4e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.99e-06	2.26e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.98e-06	2.26e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.63e-06	2.06e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CREBBP—esophageal cancer	3.53e-06	2e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.48e-06	1.98e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NOS3—esophageal cancer	3.16e-06	1.79e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS2—esophageal cancer	2.89e-06	1.64e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—EP300—esophageal cancer	2.4e-06	1.36e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.33e-06	1.32e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NOS3—esophageal cancer	2.08e-06	1.18e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.91e-06	1.08e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.78e-06	1.01e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—EP300—esophageal cancer	1.59e-06	8.99e-06	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.17e-06	6.65e-06	CbGpPWpGaD
